Filing Details

Accession Number:
0001179110-17-011866
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-28 18:28:54
Reporting Period:
2017-08-24
Accepted Time:
2017-08-28 17:28:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc ABMD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1139301 Md A Eric Rose C/O Abiomed, Inc.
22 Cherry Hill Drive
Danvers MA 01923
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Acquisiton 2017-08-24 12,000 $18.63 24,652 No 4 M Direct
Common Stock, $.01 Par Value Acquisiton 2017-08-24 11,018 $7.67 35,670 No 4 M Direct
Common Stock, $.01 Par Value Disposition 2017-08-24 10,397 $150.40 25,273 No 4 S Direct
Common Stock, $.01 Par Value Acquisiton 2017-08-24 11,021 $151.54 14,252 No 4 S Direct
Common Stock, $.01 Par Value Disposition 2017-08-24 1,600 $152.42 12,652 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-08-24 12,000 $0.00 12,000 $18.63
Common Stock Stock Option (right to buy) Disposition 2017-08-24 11,018 $0.00 12,000 $7.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-08-13 2018-08-13 No 4 M Direct
982 2010-08-12 2019-08-12 No 4 M Direct
Footnotes
  1. Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  2. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $150.0000 and $150.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  3. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $151.0200 and $152.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  4. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $152.0200 and $153.3100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer..